These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 30506334)
1. Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test. Madiha S; Haider S Metab Brain Dis; 2019 Feb; 34(1):297-308. PubMed ID: 30506334 [TBL] [Abstract][Full Text] [Related]
2. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine. Santiago RM; Barbieiro J; Lima MM; Dombrowski PA; Andreatini R; Vital MA Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1104-14. PubMed ID: 20547199 [TBL] [Abstract][Full Text] [Related]
4. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin. Santiago RM; Barbiero J; Gradowski RW; Bochen S; Lima MM; Da Cunha C; Andreatini R; Vital MA Behav Brain Res; 2014 Feb; 259():70-7. PubMed ID: 24183944 [TBL] [Abstract][Full Text] [Related]
5. Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration. Morais LH; Lima MM; Martynhak BJ; Santiago R; Takahashi TT; Ariza D; Barbiero JK; Andreatini R; Vital MA Pharmacol Rep; 2012; 64(5):1081-90. PubMed ID: 23238465 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of curcumin against rotenone-induced rat model of Parkinson's disease: in vivo electrophysiological and behavioral study. Darbinyan LV; Hambardzumyan LE; Simonyan KV; Chavushyan VA; Manukyan LP; Badalyan SA; Khalaji N; Sarkisian VH Metab Brain Dis; 2017 Dec; 32(6):1791-1803. PubMed ID: 28695411 [TBL] [Abstract][Full Text] [Related]
7. Amelioration of motor and non-motor deficits and increased striatal APoE levels highlight the beneficial role of pistachio supplementation in rotenone-induced rat model of PD. Haider S; Madiha S; Batool Z Metab Brain Dis; 2020 Oct; 35(7):1189-1200. PubMed ID: 32529399 [TBL] [Abstract][Full Text] [Related]
8. Protective Effect of (-)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats. Tseng HC; Wang MH; Chang KC; Soung HS; Fang CH; Lin YW; Li KY; Yang CC; Tsai CC Neurotox Res; 2020 Mar; 37(3):669-682. PubMed ID: 31811588 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Therapeutic Effect of Curcumin-Conjugated Zinc Oxide Nanoparticles on Reserpine-Induced Depression in Wistar Rats. Fahmy HM; Aboalasaad FA; Mohamed AS; Elhusseiny FA; Khadrawy YA; Elmekawy A Biol Trace Elem Res; 2024 Jun; 202(6):2630-2644. PubMed ID: 37713054 [TBL] [Abstract][Full Text] [Related]
10. Demethoxycurcumin ameliorates rotenone-induced toxicity in rats. Ramkumar M; Rajasankar S; Swaminathan Johnson WM; Prabu K; Venkatesh Gobi V Front Biosci (Elite Ed); 2019 Jan; 11(1):1-11. PubMed ID: 30468633 [TBL] [Abstract][Full Text] [Related]
11. Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression. Rinwa P; Kumar A; Garg S PLoS One; 2013; 8(4):e61052. PubMed ID: 23613781 [TBL] [Abstract][Full Text] [Related]
12. The effects of curcumin on depressive-like behaviors in mice. Xu Y; Ku BS; Yao HY; Lin YH; Ma X; Zhang YH; Li XJ Eur J Pharmacol; 2005 Jul; 518(1):40-6. PubMed ID: 15987635 [TBL] [Abstract][Full Text] [Related]
13. Analysis of anti-depressant potential of curcumin against depression induced male albino wistar rats. Chang XR; Wang L; Li J; Wu DS Brain Res; 2016 Jul; 1642():219-225. PubMed ID: 26972530 [TBL] [Abstract][Full Text] [Related]
14. Involvement of the Dorsal Hippocampus 5-HT1A Receptors in the Regulation of Depressive-Like Behaviors in Hemiparkinsonian Rats. Jiang YF; Liu J; Yang J; Guo Y; Hu W; Zhang J; La XM; Xie W; Wang HS; Zhang L Neuropsychobiology; 2020; 79(3):198-207. PubMed ID: 31940619 [TBL] [Abstract][Full Text] [Related]
15. Curcumin Monoglucoside Shows Improved Bioavailability and Mitigates Rotenone Induced Neurotoxicity in Cell and Drosophila Models of Parkinson's Disease. Pandareesh MD; Shrivash MK; Naveen Kumar HN; Misra K; Srinivas Bharath MM Neurochem Res; 2016 Nov; 41(11):3113-3128. PubMed ID: 27535828 [TBL] [Abstract][Full Text] [Related]
16. Antidepressant effects of curcumin-coated iron oxide nanoparticles in a rat model of depression. Khadrawy YA; Hosny EN; Magdy M; Mohammed HS Eur J Pharmacol; 2021 Oct; 908():174384. PubMed ID: 34324858 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats. Bassani TB; Gradowski RW; Zaminelli T; Barbiero JK; Santiago RM; Boschen SL; da Cunha C; Lima MM; Andreatini R; Vital MA Brain Res; 2014 Dec; 1593():95-105. PubMed ID: 25301688 [TBL] [Abstract][Full Text] [Related]
19. Putative role of monoamines in the antidepressant-like mechanism induced by striatal MT2 blockade. Noseda AC; Rodrigues LS; Targa AD; Aurich MF; Vital MA; Da Cunha C; Lima MM Behav Brain Res; 2014 Dec; 275():136-45. PubMed ID: 25218873 [TBL] [Abstract][Full Text] [Related]
20. The nonsteroidal antiinflammatory drug piroxicam reverses the onset of depressive-like behavior in 6-OHDA animal model of Parkinson's disease. Santiago RM; Tonin FS; Barbiero J; Zaminelli T; Boschen SL; Andreatini R; Da Cunha C; Lima MM; Vital MA Neuroscience; 2015 Aug; 300():246-53. PubMed ID: 25999296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]